Company intelligence / Profile preview
Quiver Bioscience
Cambridge, Massachusetts, United Statesquiverbioscience.com ↗
- Ownership
- Private
- Employees
- ~48
- Development stage
- Preclinical
01
Overview
The company has multiple preclinical programs targeting neurological disorders, with no programs yet in clinical trials as of May 2025.
- Therapeutic areas
- Neurology
- Modalities
- Antisense Oligonucleotides (ASO)Small Molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
QurAlis (ALS target)Vanqua (Parkinson's Disease target)Chamishi Therapeutics (joint venture with The Silverstein Foundation)
Beyond the preview
Go deeper on Quiver Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quiver Bioscience.